Place of Recent Approvals in Parkinson Disease Management

Video content above is prompted by the following:

Place of New Approvals in Parkinson Disease Management

• Expanding options for personalized treatment approaches
• Filling treatment gap between conventional oral therapy and surgical interventions
• Greater flexibility in addressing individual symptom patterns
• Potential for earlier intervention with advanced therapies
• Complementary mechanisms allowing for targeted symptom management
• Options for patients ineligible for certain treatments (eg, deep brain stimulation)
• Need for comparative effectiveness studies to guide selection
• Cost-effectiveness considerations affecting accessibility
• Potential to delay disease progression through improved symptom control
• Opportunity to address previously undertreated population of patients